ClassID:

95188

C07D333/40 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals Thiophene-2-carboxylic acid

Recent Application in this class:
#1
20260132106
2026-05-14

FABP4/5 INHIBITORS, METHODS OF USE AND METHODS OF MAKING

#2
20260063994
2026-03-05

RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN AND ONIUM SALT COMPOUND

#3
20240391864
2024-11-28

INSECT REPELLENT COMPOUNDS AND COMPOSITIONS, AND METHODS THEREOF

#4
20240336567
2024-10-10

PESTICIDAL AND HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF

#5
20240317733
2024-09-26

CYCLOPROPANAMINE COMPOUND AND USE THEREOF

#6
20240199572
2024-06-20

COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA

#7
20240199535
2024-06-20

DEUTERATED DHODH INHIBITORS

#8
20230278979
2023-09-07

SALTS OF A DIHYDROOROTATE DEHYDROGENASE (DHOD) INHIBITOR

#9
20230174457
2023-06-08

INSECT REPELLENT COMPOUNDS AND COMPOSITIONS, AND METHODS THEREOF

#10
20230152691
2023-05-18

SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN

#11
20230150931
2023-05-18

FABP4/5 INHIBITORS, METHODS OF USE AND METHODS OF MAKING

#12
20230113502
2023-04-13

LOW ENERGY GAP SMALL MOLECULE MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE USING THE SAME

#13
20230046892
2023-02-16

SUBSTITUTED THIOPHENE CARBOXAMIDES, THIOPHENE CARBOXYLIC ACIDS AND DERIVATIVES THEREOF

#14
20220304984
2022-09-29

AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF

#15
20220298173
2022-09-22

Neprilysin inhibitors

#16
20220202772
2022-06-30

COMPOSITIONS AND METHODS FOR INHIBITING RIBOSOME INACTIVATING PROTEINS

#17
20210363141
2021-11-25

Dual mechanism inhibitors for the treatment of disease

#18
20210179603
2021-06-17

CYCLOPROPANAMINE COMPOUND AND USE THEREOF

#19
20210107859
2021-04-15

A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS

#20
20210079017
2021-03-18

Neprilysin inhibitors

#21
20200347026
2020-11-05

PROCESSES FOR THE PREPARATION OF HETEROARYL CARBOXYLIC ACIDS

#22
20200131171
2020-04-30

Dual mechanism inhibitors for the treatment of disease

#23
20200085957
2020-03-19

Lipids for therapeutic agent delivery formulations

#24
20200079727
2020-03-12

2-(substituted benzene matrix) aromatic formate FTO inhibitor, preparation method therefor, and applications thereof

#25
20200031847
2020-01-30

Neprilysin inhibitors

#26
20200002324
2020-01-02

Dual mechanism inhibitors for the treatment of disease

#27
20190315735
2019-10-17

Cyclopropanamine compound and use thereof

#28
20190256489
2019-08-22

Tetrahydrothiophene-based GABA aminotransferase inactivators and analogs thereof for treating neurological disorders

#29
20190248759
2019-08-15

Method for producing 3-methyl-2-thiophenecarboxylic acid

#30
20190202801
2019-07-04

Piperazine carbamates and methods of making and using same

#31
20190062299
2019-02-28

Processes for the preparation of heteroaryl carboxylic acids

#32
20190047937
2019-02-14

Insect repellent compounds and compositions, and methods thereof

#33
20180244666
2018-08-30

Dual mechanism inhibitors for the treatment of disease

#34
20180230122
2018-08-16

PRODUCTION METHOD FOR HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE, PRODUCTION INTERMEDIATE THEREOF, AND CRYSTAL

#35
20180215749
2018-08-02

Dual mechanism inhibitors for the treatment of disease

#36
20180194776
2018-07-12

Neprilysin inhibitors

#37
20180162853
2018-06-14

Cyclopropanamine compound and use thereof

#38
20180051001
2018-02-22

Tetrahydrothiophene-based GABA aminotransferase inactivators

#39
20170320895
2017-11-09

Neprilysin inhibitors

#40
20170240485
2017-08-24

Synthesis of Esters by Functionalisation of CO2

#41
20170217910
2017-08-03

INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES

#42
20170144999
2017-05-25

Therapeutic substituted cyclopentanes

#43
20170081304
2017-03-23

Quaternary ammonium alkyl esters as stable prodrugs

#44
20170057941
2017-03-02

Substituted arylcyclopentenes as therapeutic agents

#45
20170029417
2017-02-02

Cyclopropanamine compound and use thereof

#46
20170022219
2017-01-26

Neprilysin inhibitors

#47
20170001994
2017-01-05

Cyclopropanamine compound and use thereof

#48
20160376249
2016-12-29

PRODUCTION METHOD FOR HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE, PRODUCTION INTERMEDIATE THEREOF, AND CRYSTAL

#49
20160331782
2016-11-17

Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin

#50
20160311814
2016-10-27

Cyclopropanamine compound and use thereof

#51
20160311808
2016-10-27

Cyclopropanamine compound and use thereof

#52
20160264544
2016-09-15

Tetrahydrothiophene-based GABA aminotransferase inactivators

#53
20160185743
2016-06-30

15-oxospiramilactone derivatives, preparation method and uses thereof

#54
20160176856
2016-06-23

Compositions and Methods for the Treatment of Norovirus Infection

#55
20160074514
2016-03-17

Lipids for therapeutic agent delivery formulations

#56
20160058734
2016-03-03

Heteroarylcarboxylic acid ester derivative

#57
20160031847
2016-02-04

Guanidinobenzoic acid ester compound

#58
20150344415
2015-12-03

Shikonin, alkannin; and racemic parent nucleus cabonyl oxime derivatives and applications thereof

#59
20150291577
2015-10-15

Cyclopropanamine compound and use thereof

#60
20150272120
2015-10-01

Dihydrothiophene derivatives as insecticidal compounds

#61
20150258048
2015-09-17

Therapeutic agents

#62
20150197530
2015-07-16

Useful thiophene derivatives in the treatment of diabetes

#63
20150174089
2015-06-25

Substituted aminobutyric derivatives as neprilysin inhibitors

#64
20150148550
2015-05-28

Compounds as chloride channel blocking agent

#65
20150119426
2015-04-30

Modulators of the relaxin receptor 1

#66
20150099733
2015-04-09

Heteroarylcarboxylic acid ester derivative

#67
20150018411
2015-01-15

COMPOUNDS AS PPAR BETA/DELTA INHIBITORS FOR TREATING PPAR BETA/DELTA-MEDIATED DISEASES

#68
20140378459
2014-12-25

Guanidinobenzoic acid compound

#69
20140323558
2014-10-30

Therapeutic agents

#70
20140323510
2014-10-30

Substituted arylcyclopentenes as therapeutic agents

#71
20140249163
2014-09-04

Malignant and non-malignant disease treatment with Ras antagonists

#72
20140235703
2014-08-21

THIOPHENE COMPOUNDS

#73
20140213552
2014-07-31

Cyclohexylamines

#74
20140206888
2014-07-24

METHODS FOR PREPARATION OF THIOPHENE COMPOUNDS

#75
20140187617
2014-07-03

DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE

#76
20140171661
2014-06-19

Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes

#77
20140065103
2014-03-06

COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS

#78
20130338132
2013-12-19

Heteroarylcarboxylic acid ester derivative

#79
20130330401
2013-12-12

Lipids for therapeutic agent delivery formulations

#80
20130310573
2013-11-21

Process for the preparation of strontium ranelate

#81
20130136719
2013-05-30

COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS

#82
20130123242
2013-05-16

COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS

#83
20130101667
2013-04-25

Cyclohexylamines

#84
20130085127
2013-04-04

Heterocyclic compound and H1 receptor antagonist

#85
20130052161
2013-02-28

Inhibitors of flaviviridae viruses

#86
20130005767
2013-01-03

THERAPEUTIC COMPOUNDS

#87
20120323019
2012-12-20

METHOD FOR CARBOXYLIZING AROMATES AND HETETOAROMATES USING CO2

#88
20120301430
2012-11-29

Thiophene analogues for the treatment or prevention of flavivirus infections

#89
20120270877
2012-10-25

IRE-1α inhibitors

#90
20120252830
2012-10-04

Substituted aminobutyric derivatives as neprilysin inhibitors

#91
20120225940
2012-09-06

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia

#92
20120209005
2012-08-16

Fused heterocyclic compounds and thrombopoietin receptor activators

#93
20120178798
2012-07-12

Substituted cyclopentanes having prostaglandin activity

#94
20120157516
2012-06-21

Substituted thiophene pentamers

#95
20120157383
2012-06-21

Neprilysin inhibitors

#96
20120135984
2012-05-31

DUAL-ACTION INHBITORS AND METHODS OF USING SAME

#97
20120108573
2012-05-03

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

#98
20120101137
2012-04-26

NOVEL THIOPHENECARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF

#99
20120059170
2012-03-08

Thiophene analogues for the treatment or prevention of flavivirus infections

#100
20120035251
2012-02-09

THIOPHENE INHIBITORS OF IKK-B SERINE-THREONINE PROTEIN KINASE

#101
20120015978
2012-01-19

Therapeutic agents for ocular hypertension

#102
20110306775
2011-12-15

SYNTHESIS AND BIOLOGICAL EVALUATION OF 2',5'-DIMETHOXYCHALCONE DERIVATIVES AS MICROTUBULE-TARGETED ANTICANCER AGENTS

#103
20110281919
2011-11-17

Treatment of a stomach or small intestine ulcer with 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid

#104
20110263692
2011-10-27

Therapeutic compounds

#105
20110257182
2011-10-20

Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

#106
20110213157
2011-09-01

Tricyclic amide compound

#107
20110213156
2011-09-01

5-membered heterocyclic compound

#108
20110200553
2011-08-18

Compounds and methods for the treatment or prevention of infections

#109
20110190286
2011-08-04

Therapeutically active cyclopentanes

#110
20110184055
2011-07-28

Therapeutic agents for treatment of ocular hypertension

#111
20110172299
2011-07-14

Therapeutic substituted cyclopentanes

#112
20110166342
2011-07-07

7-membered ring compound and method of production and pharmaceutical application thereof

#113
20110144069
2011-06-16

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#114
20110112311
2011-05-12

Method for producing 3-methyl-2-thiophenecarboxylic acid

#115
20110112075
2011-05-12

Chlorothiophene-amides as inhibitors of coagulation factors Xa and thrombin

#116
20110062165
2011-03-17

Therapeutic substituted cyclopentanes

#117
20110059967
2011-03-10

Therapeutic compounds

#118
20100317582
2010-12-16

Cyclic hydrocarbon compounds for the treatment of diseases

#119
20100305145
2010-12-02

Substituted aminobutyric derivatives as neprilysin inhibitors

#120
20100280011
2010-11-04

Dual mechanism inhibitors for the treatment of disease

#121
20100267945
2010-10-21

Amine derivative having NPY Y5 receptor antagonistic activity

#122
20100261735
2010-10-14

Fungicidal composition containing acid amide derivative

#123
20100261675
2010-10-14

FUNGICIDAL COMPOSITION CONTAINING ACID AMIDE DERIVATIVE

#124
20100240904
2010-09-23

PROCESSES FOR THE PREPARATION OF N-(2-ACETYL-4,6-DIMETHYLPHENYL)-3--2-THIOPHENECARBOXAMIDE

#125
20100173981
2010-07-08

Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension

#126
20100143404
2010-06-10

Thiophene derivatives for up-regulating HLA-DM activity

#127
20100137336
2010-06-03

NOVEL AMIDO DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS

#128
20100105900
2010-04-29

Inhibitors of carnitine palmitoyltransferase and treating cancer

#129
20100093855
2010-04-15

Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia

#130
20100068178
2010-03-18

Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers

#131
20100063027
2010-03-11

Amine derivative having NPY Y5 receptor antagonistic activity

#132
20100029735
2010-02-04

Therapeutic compounds

#133
20090325925
2009-12-31

Thiophenes and uses thereof

#134
20090318711
2009-12-24

Non-Covalent Inhibitors of AmpC ß-Lactamase

#135
20090318704
2009-12-24

Processes for the Preparation of N-(2-Acetyl-4,6-Dimethylphenyl)-3--2-Thiophenecarboxamide

#136
20090312328
2009-12-17

Sulfonamide compound or salt thereof

#137
20090286793
2009-11-19

PDE4B inhibitors and uses therefor

#138
20090227573
2009-09-10

Substituted cyclopentanes having prostaglandin activity

#139
20090192151
2009-07-30

Therapeutic amides and related compounds

#140
20090170891
2009-07-02

Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment

#141
20090143461
2009-06-04

Substituted cyclopentanes having prostaglandin activity

#142
20090124676
2009-05-14

Substituted cyclopentanes having prostaglandin activity

#143
20090111796
2009-04-30

7-membered ring compound and method of production and pharmaceutical application thereof

#144
20090105203
2009-04-23

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#145
20090069382
2009-03-12

Bicyclic angiotensin II agonists

#146
20090062287
2009-03-05

Substituted biaryl compounds as factor XIa inhibitors

#147
20090036428
2009-02-05

Methods for treating an ulcer of the small intestine and stomach

#148
20090016981
2009-01-15

THERAPEUTIC COMPOUNDS

#149
20080318779
2008-12-25

Fungicidal composition containing acid amide derivative

#150
20080312321
2008-12-18

Therapeutic substituted cyclopentanes

#151
20080300269
2008-12-04

Therapeutic compounds

#152
20080299080
2008-12-04

Thiophene analogues for the treatment or prevention of flavivirus infections

#153
20080269481
2008-10-30

Compounds and methods for the treatment or prevention of flavivirus infections

#154
20080255198
2008-10-16

Biaryloxymethylarenecarboxylic acids as glycogen synthase activator

#155
20080249301
2008-10-09

Regioselective Process for Preparing Benzimidazole Thiophenes

#156
20080242671
2008-10-02

INHIBITORS OF CATHEPSIN S

#157
20080221101
2008-09-11

Calcium receptor modulating agents

#158
20080207573
2008-08-28

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#159
20080200468
2008-08-21

2-Substituted 5-Membered Heteroaryl Carboxylates as Hm74a Receptor Agonists

#160
20080153850
2008-06-26

Adamantyl Derivates as P2x7 Receptor Antagonists

#161
20080119539
2008-05-22

Therapeutic amides

#162
20080108662
2008-05-08

Biaryloxymethylarenecarboxylic acids as glycogen synthase activator

#163
20080096936
2008-04-24

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

#164
20080086011
2008-04-10

Processes for the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide

#165
20080027060
2008-01-31

DIPEPTIDE NITRILES

#166
20080027048
2008-01-31

2-phenylthiophene derivative

#167
20070293561
2007-12-20

Therapeutic compounds

#168
20070259947
2007-11-08

Therapeutic compounds

#169
20070259836
2007-11-08

Therapeutic cyclopentane derivatives

#170
20070129552
2007-06-07

Therapeutic substituted cyclopentanes

#171
20070111971
2007-05-17

Triphenylethylene compounds as selective estrogen receptor modulators

#172
20070043045
2007-02-22

High affinity thiophene-based and furan-based kinase ligands

#173
20070032475
2007-02-08

Novel compounds useful for bradykinin B1 receptor antagonism

#174
20060287536
2006-12-21

Phenyl-thiophene type vitamin D receptor modulators

#175
20060235220
2006-10-19

Dipeptide nitriles

#176
20060229310
2006-10-12

Antibacterial compounds

#177
20060154915
2006-07-13

Substituted biaryl compounds as factor XIa inhibitors

#178
20060122184
2006-06-08

Cyanomethyl derivatives as cysteine protease inhibitors

#179
20060041006
2006-02-23

PDE4B inhibitors and uses therefor

#180
20060004063
2006-01-05

Inhibitors of HCV NS5B polymerase

#181
20050009804
2005-01-13

Compounds and methods for the treatment or prevention of infections

#182
14565649
2015-04-28

Method for preparing carboxylic acids